James E. Flynn, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), sold 699,475 shares at $2.69 ($1.9M) on 2019-06-27, disclosed to the SEC on 2019-07-01.
Open-market sale of $1.9M ACRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.69 | 108,674 | $292K | 15.5% |
| 2 | $2.69 | 590,801 | $1.6M | 84.5% |
| Total | $2.69 avg | 699,475 | $1.9M | 100% |
| Filing → |
| SPRY | SELL | 2025-07-01 | $27.3M | — | Filing → |
| ONCR | SELL | 2022-12-30 | $65K | — | Filing → |
| ONCR | SELL | 2022-12-21 | $23K | — | Filing → |